Aberrant expression of SLC2A3 (solute carrier family 2, facilitated glucose transporter member 3) has been reported in gastric, testicular, ovarian, and NSCLC.77, 78. The gene discussed is SLC2A3; the disease is non-small cell lung carcinoma.